Standard Operating Procedure for Preventive Action Reports (PAR) for Deviations
Department | Tablet |
---|---|
SOP No. | SOP/TAB/200/2025 |
Supersedes | SOP/TAB/200/2022 |
Page No. | Page 1 of 6 |
Issue Date | 01/03/2026 |
Effective Date | 06/03/2026 |
Review Date | 01/03/2027 |
1. Purpose
To establish the procedure for the identification, documentation, and investigation of deviations from established processes and the initiation of Preventive Action Reports (PARs) to prevent recurrence.
2. Scope
This SOP applies to all tablet manufacturing processes within the facility. It covers the management of deviations from established procedures, identification of root causes, and the development of preventive actions to eliminate recurrence.
3. Responsibilities
- Quality Assurance (QA): Responsible for reviewing and approving PARs, ensuring that corrective and preventive actions are effectively implemented, and verifying that the process remains in control.
- Production Team: Responsible for identifying deviations during tablet manufacturing and reporting them immediately to the QA team. They also assist in implementing corrective and preventive actions.
- Regulatory Affairs: Ensures that the PAR process complies with applicable regulatory requirements, such as FDA and GMP guidelines.
- CAPA Coordinator: Responsible for ensuring that all preventive actions are documented, tracked, and verified for effectiveness.
4. Accountability
The QA Manager is accountable for overseeing the entire PAR process, including approval of preventive actions. The Production Manager is accountable for ensuring that deviations are immediately addressed and that the necessary preventive actions are implemented.
5. Procedure
5.1 Identification of Deviations
- Monitor manufacturing processes for any deviation from standard operating procedures (SOPs), batch records, or regulatory requirements during tablet production.
- Identify deviations as soon as they occur and immediately report them to the QA team for review and investigation.
- Document all deviations in the deviation log (Annexure-1), including details such as the date of occurrence, the operator involved, the nature of the deviation, and the corrective actions taken.
5.2 Documentation of Preventive Action Report (PAR)
- If a deviation is found to be significant, initiate a Preventive Action Report (PAR) by documenting the event and the root cause analysis in the PAR log (Annexure-2).
- Include details of the deviation, the reason for its occurrence, the potential impact on product quality, and the proposed preventive actions in the PAR documentation.
- Ensure that the PAR includes the date of the event, personnel involved, and a summary of the preventive measures to prevent recurrence.
5.3 Root Cause Analysis
- Conduct a root cause analysis (RCA) for each significant deviation to determine the underlying causes of the event. This may include equipment failure, operator error, material issues, or process inconsistencies.
- Use appropriate RCA tools such as Fishbone Diagrams, 5 Whys, or Fault Tree Analysis to identify the root cause.
- Document the findings of the RCA and use them to design effective preventive actions (Annexure-3).
5.4 Preventive Action Implementation
- Based on the root cause analysis, develop preventive actions aimed at eliminating the root cause of the deviation and preventing its recurrence.
- Implement corrective actions and preventive actions (CAPA) immediately after the PAR is raised. These may include process adjustments, training, equipment maintenance, or changes in material handling (Annexure-4).
- Ensure that all corrective actions are tracked and verified for effectiveness during follow-up reviews.
5.5 Monitoring and Effectiveness Check
- Monitor the effectiveness of the preventive actions implemented through follow-up checks, audits, and process verification.
- Review any similar deviations or re-occurrence of the issue after the preventive actions have been implemented to verify their success in eliminating the root cause.
- Document the results of the follow-up checks in the PAR log (Annexure-5) and close the report once it is verified that the preventive actions have been successful.
5.6 Documentation and Record Keeping
- Maintain all PAR documentation, including deviation reports, root cause analysis findings, and corrective action records, in compliance with regulatory guidelines and internal SOPs.
- Ensure that all records are properly filed and stored for future reference and audits. These records should be accessible for review during regulatory inspections (Annexure-6).
5.7 Reporting to Regulatory Authorities
- If required, submit the PAR details to regulatory authorities (e.g., FDA, EMA) for further review and compliance. Include any changes made to manufacturing practices or quality assurance protocols in the submission.
- Ensure that all regulatory reporting is completed on time and accurately.
6. Abbreviations
- SOP: Standard Operating Procedure
- QA: Quality Assurance
- CAPA: Corrective and Preventive Action
- PAR: Preventive Action Report
- RCA: Root Cause Analysis
7. Documents
- Deviation Log (Annexure-1)
- PAR Log (Annexure-2)
- Root Cause Analysis (Annexure-3)
- CAPA Documentation (Annexure-4)
- PAR Follow-up Log (Annexure-5)
- Regulatory Reporting Log (Annexure-6)
8. References
- 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
- ISO 9001 – Quality Management Systems
- ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
9. SOP Version
Version: 2.0
10. Approval Section
Prepared By | Checked By | Approved By | |
---|---|---|---|
Signature | |||
Date | |||
Name | |||
Designation | |||
Department |
11. Annexures
Annexure-1: Deviation Report
Deviation ID | Deviation Description | Operator | Date | Action Taken |
---|---|---|---|---|
DEV-001 | Deviation in tablet compression force | John Doe | 01/03/2026 | Adjusted compression force |
Annexure-2: Preventive Action Report (PAR) Log
PAR ID | Deviation Description | Corrective Action | Preventive Action | Completion Date |
---|---|---|---|---|
PAR-001 | Deviation in tablet hardness | Recalibrated press | Updated SOPs for press calibration | 01/04/2026 |
Annexure-3: Root Cause Analysis (RCA)
RCA ID | Cause Description | Investigation Findings | Corrective Action |
---|---|---|---|
RCA-001 | Inconsistent tablet weight | Operator error in material dispensing | Re-trained operator on correct material dispensing |
Annexure-4: CAPA Documentation
CAPA ID | Action Description | Responsible Person | Completion Date |
---|---|---|---|
CAPA-001 | Corrected deviation in tablet weight | Jane Smith | 01/05/2026 |
Annexure-5: PAR Follow-up Log
PAR ID | Follow-up Action | Completion Date | Status |
---|---|---|---|
PAR-001 | Completed requalification of tablet press | 01/05/2026 | Completed |
Annexure-6: Regulatory Reporting Log
Report | Submission Date | Authority | Status |
---|---|---|---|
PAR Submission | 01/06/2026 | FDA | Submitted |
Revision History:
Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
---|---|---|---|---|
01/01/2024 | 1.0 | Initial Version | New SOP Creation | QA Head |
01/02/2025 | 2.0 | Added preventive actions review | Improved corrective actions | QA Head |